tetano
Editor, Senior Moderator
Prev Med
. 2021 Jul 16;106727.
doi: 10.1016/j.ypmed.2021.106727. Online ahead of print.
The role of trust in the likelihood of receiving a COVID-19 vaccine: Results from a national survey
Peter G Szilagyi[SUP] 1 [/SUP], Kyla Thomas[SUP] 2 [/SUP], Megha D Shah[SUP] 3 [/SUP], Nathalie Vizueta[SUP] 4 [/SUP], Yan Cui[SUP] 3 [/SUP], Sitaram Vangala[SUP] 5 [/SUP], Craig Fox[SUP] 6 [/SUP], Arie Kapteyn[SUP] 2 [/SUP]
Affiliations
Abstract
High acceptance of coronavirus disease 2019 (COVID-19) vaccines is instrumental to ending the pandemic. Vaccine acceptance by subgroups of the population depends on their trust in COVID-19 vaccines. We surveyed a probability-based internet panel of 7832 adults from December 23, 2020-January 19, 2021 about their likelihood of getting a COVID-19 vaccine and the following domains of trust: an individual's generalized trust, trust in COVID-19 vaccine's efficacy and safety, trust in the governmental approval process and general vaccine development process for COVID-19 vaccines, trust in their physician about COVID-19, and trust in other sources about COVID-19. We included identified at-risk subgroups: healthcare workers, older adults (65-74-year-olds and ≥ 75-year-olds), frontline essential workers, other essential workers, and individuals with high-risk chronic conditions. Of 5979 respondents, only 57.4% said they were very likely or somewhat likely to get a COVID-19 vaccine. More hesitant respondents (p < 0.05) included: women, young adults (18-49 years), Blacks, individuals with lower education, those with lower income, and individuals without high-risk chronic conditions. Lack of trust in the vaccine approval and development processes explained most of the demographic variation in stated vaccination likelihood, while other domains of trust explained less variation. We conclude that hesitancy for COVID-19 vaccines is high overall and among at-risk subgroups, and hesitancy is strongly tied to trust in the vaccine approval and development processes. Building trust is critical to ending the pandemic.
Keywords: COVID-19; Essential workers; Older adults; Racial/ethnic minorities; Trust; Underserved communities; Vaccination.
. 2021 Jul 16;106727.
doi: 10.1016/j.ypmed.2021.106727. Online ahead of print.
The role of trust in the likelihood of receiving a COVID-19 vaccine: Results from a national survey
Peter G Szilagyi[SUP] 1 [/SUP], Kyla Thomas[SUP] 2 [/SUP], Megha D Shah[SUP] 3 [/SUP], Nathalie Vizueta[SUP] 4 [/SUP], Yan Cui[SUP] 3 [/SUP], Sitaram Vangala[SUP] 5 [/SUP], Craig Fox[SUP] 6 [/SUP], Arie Kapteyn[SUP] 2 [/SUP]
Affiliations
- PMID: 34280405
- DOI: 10.1016/j.ypmed.2021.106727
Abstract
High acceptance of coronavirus disease 2019 (COVID-19) vaccines is instrumental to ending the pandemic. Vaccine acceptance by subgroups of the population depends on their trust in COVID-19 vaccines. We surveyed a probability-based internet panel of 7832 adults from December 23, 2020-January 19, 2021 about their likelihood of getting a COVID-19 vaccine and the following domains of trust: an individual's generalized trust, trust in COVID-19 vaccine's efficacy and safety, trust in the governmental approval process and general vaccine development process for COVID-19 vaccines, trust in their physician about COVID-19, and trust in other sources about COVID-19. We included identified at-risk subgroups: healthcare workers, older adults (65-74-year-olds and ≥ 75-year-olds), frontline essential workers, other essential workers, and individuals with high-risk chronic conditions. Of 5979 respondents, only 57.4% said they were very likely or somewhat likely to get a COVID-19 vaccine. More hesitant respondents (p < 0.05) included: women, young adults (18-49 years), Blacks, individuals with lower education, those with lower income, and individuals without high-risk chronic conditions. Lack of trust in the vaccine approval and development processes explained most of the demographic variation in stated vaccination likelihood, while other domains of trust explained less variation. We conclude that hesitancy for COVID-19 vaccines is high overall and among at-risk subgroups, and hesitancy is strongly tied to trust in the vaccine approval and development processes. Building trust is critical to ending the pandemic.
Keywords: COVID-19; Essential workers; Older adults; Racial/ethnic minorities; Trust; Underserved communities; Vaccination.